Improved host range selection for recombinant modified vaccinia virus Ankara
Staib, C.; Löwel, M.; Erfle, V.; Sutter, G.
Biotechniques 34(4): 694
2003
ISSN/ISBN: 0736-6205 PMID: 12703290 Document Number: 558541
Document emailed within 1 workday
Related Documents
Ferrer, M.F.; Zanetti, F.A.; Calamante, G. 2007: Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA) Revista Argentina de Microbiologia 39(3): 138-142Ramanathan, V.D.; Kumar, M.; Mahalingam, J.; Sathyamoorthy, P.; Narayanan, P.R.; Solomon, S.; Panicali, D.; Chakrabarty, S.; Cox, J.; Sayeed, E.; Ackland, J.; Verlinde, C.; Vooijs, D.; Loughran, K.; Barin, B.; Lombardo, A.; Gilmour, J.; Stevens, G.; Smith, M.S.; Tarragona-Fiol, T.; Hayes, P.; Kochhar, S.; Excler, J.-L.; Fast, P. 2009: A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers Aids Research and Human Retroviruses 25(11): 1107-1116
Chen, H.; Padmanabhan, R. 1994: A modified method for isolation of recombinant vaccinia virus Biotechniques 17(1): 40; 42
Sláviková, K.; Altaner, C. 1981: Host range of murine sarcoma virus, its host modification and phenotypic mixing with endogenous virus Neoplasma 28(2): 159-169
Haishi, S.; Imai, H.; Hirai, K.; Igarashi, A.; Kato, S. 1989: Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus Acta Virologica 33(6): 497-503
Sviatchenko, V.A.; Agapov, E.V.; Urmanov, I.Kh.; Serpinskiĭ, O.I.; Frolov, I.V.; Kolykhalov, A.A.; Ryzhikov, A.B.; Netesov, S.V. 1993: The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus Voprosy Virusologii 38(5): 222-226
Timiryasova, T.M.; Chen, B.; Fodor, N.; Fodor, I. 2001: Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper Biotechniques 31(3): 534 536 538-40
Chakrabarti, S.; Robert-Guroff, M.; Wong-Staal, F.; Gallo, R.C.; Moss, B. 1986: Expression of the HTLV-III envelope gene by a recombinant vaccinia virus Nature 320(6062): 535-537
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Han, S.W.; Zhu, Q.Y.; Zhao, L.Q.; Fang, J.M. 1989: Expression of hepatitis B core antigen gene in recombinant vaccinia virus Chinese Journal of Biotechnology 5(3): 141-148
Irvine, K.R.; McCabe, B.J.; Rosenberg, S.A.; Restifo, N.P. 1995: Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL Journal of Immunology 154(9): 4651-4657
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990
Prasad, C.B.; Hedström, K.G. 1974: Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 148(2): 97-111
Russo, G.; Mertens, K.; De Magistris, L.; Lange, H.; Cortese, R.; Pietropaolo, C. 1991: Biologically active recombinant prothrombin and antithrombin IIi expressed in a human hepatoma/vaccinia virus system Biotechnology and Applied Biochemistry 14(2): 222-233
Huang, W.; Tian, H-wen.; Ren, J.; Fan, J-tao.; Zhao, L.; Bian, T.; Lu, Z-hua.; Ruan, L. 2005: Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 19(3): 240-243
Kantor, J.; Irvine, K.; Abrams, S.; Snoy, P.; Olsen, R.; Greiner, J.; Kaufman, H.; Eggensperger, D.; Schlom, J. 1992: Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate Cancer Research 52(24): 6917-6925
Topa, P.K.; Rao, K.V. 1976: Extraction of vaccinia virus and purification of vaccinia elementary body suspension with Mafron 11 Indian Journal of Medical Research 64(10): 1421-1431
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Diotti, R.A.; Sautto, G.A.; Solforosi, L.; Mancini, N.; Clementi, M.; Burioni, R. 2012: Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein New Microbiologica 35(4): 475-479